ArticleJournal for immunotherapy of cancer2023

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.

Andrea Gaißler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.